Exploring the Utility of [18F]3F4AP for Demyelination Imaging

NCT06999434 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Demyelinating Disorders
MCI
Alzheimer's Disease (AD)
MS (Multiple Sclerosis)
SCI - Spinal Cord Injury
Spinal Radiculopathy

Interventions

DRUG: [ 18F]3F4AP
DRUG: [18F]MK6240
DRUG: [11C]PIB

Sponsor

Yale University

Collaborators

[object Object]
[object Object]